Table 5.
Univariate Cox regression model of clinical parameters on disease specific survival in different EOC
| Residual disease | HGSC | EC | CCC | LGSC | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard | 95.0% CI | n | Hazard | 95.0% CI | n | Hazard | 95.0% CI | n | Hazard | 95.0% CI | n | |||||||||
| Ratio | Lower | Upper | p value | Ratio | Lower | Upper | p va lue | Ratio | Lower | Upper | p value | Ratio | Lower | Upper | p value | |||||
| None | 206 | reference | 119 | reference | 93 | reference | 16 | reference | ||||||||||||
| < 1 cm | 1.72 | 1.31 | 2.23 | 230 | 0.000 | 3.80 | 1.63 | 8.84 | 29 | 0.002 | 2.24 | 1.17 | 4.29 | 26 | 0.015 | 1.10 | 0.45 | 2.72 | 21 | 0.835 |
| Suboptimal | 2.90 | 2.28 | 3.70 | 347 | 0.000 | 15.03 | 5.72 | 39.47 | 10 | 0.000 | 8.30 | 4.38 | 15.76 | 17 | 0.000 | 2.40 | 1.08 | 5.36 | 27 | 0.033 |
| Stage | ||||||||||||||||||||
| I | 70 | reference | 140 | reference | 124 | reference | 13 | reference | ||||||||||||
| II | 1.25 | 0.77 | 2.03 | 136 | 0.376 | 1.91 | 0.80 | 4.61 | 73 | 0.147 | 2.36 | 1.32 | 4.24 | 54 | 0.004 | 1.32 | 0.29 | 5.91 | 7 | 0.719 |
| III | 3.17 | 2.09 | 4.81 | 820 | 0.000 | 6.48 | 3.04 | 13.82 | 44 | 0.000 | 8.15 | 4.93 | 13.48 | 58 | 0.000 | 2.73 | 0.98 | 7.63 | 68 | 0.056 |
| IV | 4.61 | 2.93 | 7.26 | 120 | 0.000 | NA | NA | NA | 5 | NA | 19.35 | 7.57 | 49.43 | 7 | 0.000 | 7.11 | 1.87 | 27.00 | 6 | 0.004 |
Bold values highlights the statistically significant difference with the reference category
NA non applicable number of cases too low, n number of patients with follow-up, HR Hazard ratio, EOC epithelial ovarian cancer, CI confidence interval, HGSC High-Grade Serous Carcinoma, EC Endometrioid Carcinoma